Sionna Therapeutics Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Sionna Therapeutics stock has a consensus rating of "Buy" and an average price target of $51.6. The average 1-year stock price forecast is 13.93% higher than the current stock price, while the lowest is $23 (-49.22%) and the highest is $63 (+39.10%).

Price Target: $51.6 (+13.93%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$23	$51.6	$54	$63
Change	-49.22%	+13.93%	+19.23%	+39.10%

Analyst Ratings

The average analyst rating for Sionna Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	7	8	8	8	8	8
Buy	0	1	1	1	1	1
Hold	0	0	0	0	1	1
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	8	10	10	10	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Debanjana Chatterjee JonesTrading	JonesTrading	Buy Reiterates $63	Buy	Reiterates	$63	+39.10%	Jun 25, 2026
Yatin Suneja Guggenheim	Guggenheim	Buy Reiterates $50	Buy	Reiterates	$50	+10.40%	Jun 23, 2026
Gaurav Maini LifeSci Capital	LifeSci Capital	Buy Maintains $60	Buy	Maintains	$60	+32.48%	Jun 22, 2026
Paul Matteis Stifel Nicolaus	Stifel Nicolaus	Buy Maintains $55	Buy	Maintains	$55	+21.44%	May 25, 2026
Ilya Zubkov Freedom Capital Markets	Freedom Capital Markets	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	May 20, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

3.00M

EPS This Year

-2.54

from -1.88

EPS Next Year

-2.80

from -2.54

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-
Operating Income	-41.37M	-50.33M	-70.56M	-88.98M	-130.57M
Net Income	-40.24M	-47.26M	-61.69M	-75.27M	-119.18M
EPS	-	-	-	-1.88	-2.54
Free Cash Flow	-	-30.14M	-40.48M	-44.26M	-113.79M
No. Analysts	-	-	-	-	10

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-2.16
Avg	-2.54
Low	-3.43

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-